Gossamer Bio's market cap is currently ―. The company's EPS TTM is $-1.384; its P/E ratio is -0.54; Gossamer Bio is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -24.91M	$ -36.66M	$ -39.07M	$ -45.66M	$ -51.32M
EBITDA	$ -27.16M	$ -38.07M	$ -39.15M	$ -45.67M	$ -51.10M
Net Income Common Stockholders	$ -48.15M	$ -40.01M	$ -42.50M	$ -49.16M	$ -55.76M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 296.43M	$ 328.89M	$ 162.13M	$ 201.86M	$ 255.68M
Total Assets	$ 311.92M	$ 347.93M	$ 181.75M	$ 219.91M	$ 272.45M
Total Debt	$ 12.57M	$ 16.24M	$ 19.88M	$ 23.48M	$ 27.05M
Net Debt	$ -283.85M	$ -312.65M	$ -142.25M	$ -178.38M	$ -228.63M
Total Liabilities	$ 249.15M	$ 243.31M	$ 244.55M	$ 248.36M	$ 260.37M
Stockholders Equity	$ 62.77M	$ 104.62M	$ -62.82M	$ -28.46M	$ 12.08M
Cash Flow	-
Free Cash Flow	$ -33.42M	$ -34.49M	$ -38.31M	$ -52.95M	$ -47.83M
Operating Cash Flow	$ -33.42M	$ -34.49M	$ -38.31M	$ -52.95M	$ -47.73M
Investing Cash Flow	$ -14.37M	$ -118.26M	$ 12.94M	$ 8.72M	$ 8.46M
Financing Cash Flow	$ -2.90M	$ 198.50M	$ -2.90M	$ -2.54M	$ -2.87M

Currency in USD

Gossamer Bio Earnings and Revenue History

Income Statement >

Gossamer Bio Debt to Assets

Balance Sheet >

Gossamer Bio Cash Flow

Cash Flow >

Gossamer Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing